WallStSmart
SHPH

Shuttle Pharmaceuticals Inc

NASDAQ: SHPH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$1.00
-4.76% today

Updated 2026-04-29

Market cap
$5.76M
P/E ratio
P/S ratio
EPS (TTM)
$-7.16
Dividend yield
52W range
$1 – $8
Volume
0.2M

Shuttle Pharmaceuticals Inc (SHPH) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2015201620172018202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)
Cost of revenue$18739.00$18000.00$54951.00$60834.00$5972.00$6811.00$5463.00$290107.00
Gross profit$-18739.00$-18000.00$-54951.00$-60834.00$-5972.00$-6811.00$-5463.00$-290107.00
Gross margin
R&D$836.00$55572.00$161772.00$1.02M$1.05M$3.52M$3.62M$4.05M
SG&A$347750.00$721184.00$1.07M$2.38M$4.08M$7.86M
Operating income$-203890.00$-586630.00$-509522.00$-1.74M$-2.34M$-5.89M$-7.70M$-11.92M
Operating margin
EBITDA$-183971.00$-577223.00$-711151.00$-1.04M$-4.32M$-3.99M$-7.78M$-11.36M
EBITDA margin
EBIT$-291659.00$-336156.00$-202710.00$-595223.00$-766102.00$-1.10M$-4.33M$-4.00M$-7.78M$-11.65M
Interest expense$0.00$0.00$10881.00$30916.00$39630.00$50788.00$670610.00$2.60M$1.36M$70828.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-213594.00$-626139.00$-805732.00$-1.15M$-5.00M$-6.59M$-9.14M$-11.72M
Net income growth (YoY)-193.1%-28.7%-43.0%-333.6%-32.0%-38.7%-28.2%
Profit margin